Abstracts of the 21st International Conference on Pharmacepidemiology & Therapeutic Risk Management
Identifieur interne : 000219 ( Psycho/Analysis ); précédent : 000218; suivant : 000220Abstracts of the 21st International Conference on Pharmacepidemiology & Therapeutic Risk Management
Auteurs :Source :
- Pharmacoepidemiology and Drug Safety [ 1053-8569 ] ; 2005-09.
English descriptors
- Teeft :
- 1center, 1department, 1division, 1epidemiology, 1pharmacoepidemiology, 1risk, 1risk management strategy, 2clinical, 2department, 2division, 2epidemiology, 2global, 2research, 2university, 3department, 3university, 4department, 5department, Aalborg, Aalborg hospital, Aarhus, Aarhus university hospital, Acei, Aceis, Acetaminophen, Acute pancreatitis, Adalimumab, Adenoma, Adhd, Adjuvant, Adjuvant chemotherapy, Administrative databases, Adrianne, Adrs, Adverse, Adverse drug reactions, Adverse effects, Adverse event, Adverse events, Aeds, Aers, Affective, Affective disorders, African americans, Aggressive incidents, Agonist, Akira, Alendronate, Algorithm, Allergy, Alosetron, Ambulatory, Ambulatory care, Amsp, Analgesic, Anaphylaxis, Angina, Angiotensin, Antenatal, Anthonius, Antibiotic, Anticholinergic, Anticoagulant, Anticonvulsant, Antidepressant, Antidiabetic, Antiepileptic, Antiepileptic drugs, Antihypertensive, Antihypertensive drugs, Antiplatelet, Antipsychotic, Anxiety disorders, Anxiolytic, Apds, Aplastic, Aplastic anemia, Apoplexy, April, Arb, Arrhythmia, Artifact, Aspirin, Asthma, Asthma drugs, Asthmatic, Atorvastatin, Atypical, Atypical antipsychotic, Atypical antipsychotics, Auburndale, August, Autocorrelation, Autoregressive, Autoregressive parameters, Avorn, Barcelona, Baseline, Baseline period, Bayes, Bayesian, Bcpnn, Belarus, Belo, Belo horizonte, Benzodiazepine, Binary, Binder, Biologic, Biostatistics, Bipolar, Birth defects, Bisphosphonates, Blocker, Blood pressure, Body mass index, Boston university, Bowel, Bowel surgery, Bpld, Brasilia, Breast cancer, Breastfeeding, Breastfeeding women, Brigham, British columbia, Bronchodilator, Caffeine, Calcium channel blockers, Calendar year, Cardiac, Cardiac arrest, Cardiac arrhythmias, Cardiac failure, Cardiology, Cardiotoxic, Cardiovascular, Cardiovascular disease, Cardiovascular events, Cardiovascular risk, Cardiovascular risk factors, Care population, Carlos, Carvedilol, Case reports, Causality, Causation, Ccbs, Celecoxib, Centre, Cert, Chang, Chapel hill, Chemotherapy, Chhd, Cimetidine, Cisapride, Claims data, Claims database, Clinical characteristics, Clinical epidemiology, Clinical outcomes, Clinical pharmacology, Clinical pharmacy, Clinical practice, Clinical trials, Clinician, Clomiphene, Clopidogrel, Clozapine, Codeine, Cognitive impairment, Cohort, Cohort entry, Cohort study, Coinsurance, Colloid, Colorectal, Colorectal cancer, Combination therapy, Community pharmacies, Comorbid, Comorbid depression, Comorbidities, Comorbidity, Comparators, Compliant, Computerized, Concomitant, Confounders, Congenital, Congenital malformations, Consumer reports, Contraceptive, Contraindication, Control group, Copd, Copd patients, Corinne, Coronary heart disease, Corticosteroid, Coumadin, Covariates, Coxibs, Current users, Daily dose, Daily doses, Daily practice, Data mining, Database, Dataset, Deborah, December, Denmark, Denominator, Depressed patients, Depressive, Dermatitis, Descriptive statistics, Determinant, Diabetes, Diabetes medications, Diabetes mellitus, Diagnosis, Diclofenac, Digoxin, Discontinuation, Discontinuation symptoms, Disease control, Disease severity, Disorder, Dispensings, Disproportionality, Diuretic, Dmards, Dmas, Dos, Dosing, Drug, Drug administration, Drug classes, Drug safety, Drug treatment, Drug utilization, Dtca, Dundee, Durham, Dysfunction, Dyslipidemia, Ebgm, Eibert, Elderly patients, Elderly people, Eligible patients, Email, Embase, Empiric, Endpoint, Epidemiologic, Epidemiology, Epidemiology biostatistics, Epilepsy, Epoetin, Erasmus, Erasmus university, Erythromycin, Esrd, Estrogen, Etanercept, Ethnicity, Etiology, Etoricoxib, Fadia, Fasting, February, Folic, Former users, Formulary, Fracture, Fracture risk, Frequentist, Further research, Further study, Galactorrhoea, Gastric, Gastric cancer, Gastrointestinal, Gastroprotective, Gender, General population, General practice, General practice research database, General practitioners, Generic, Generic substitution, Genotype, Gerais, Gerd, Gestation, Gestational, Glaxosmithkline, Glimepiride, Glucocorticoid, Glucose, Gnrh, Goal attainment, Gprd, Groningen, Guideline, Gures, H2ras, Harvard school, Hazard ratios, Hba1c, Hcru, Health care, Health care services, Health outcomes, Health services, Health solutions, Healthcare, Healthcare professionals, Heart disease, Heart failure, Helsinki, Hemorrhagic, Hemorrhagic stroke, Henrik, Heparin, Hepatic, Her2, Herbal, High doses, High levels, High risk, Higher risk, Hopital, Horizonte, Hormone replacement therapy, Hospital admission, Hospital admissions, Hospitalier, Hospitalisation, Hospitalization, Hrqol, Hyperkalemia, Hyperlipidemia, Hypersensitivity, Hypertension, Hypertensive, Hypertensive patients, Hypospadias, Ibuprofen, Icpe, Icpe background, Icpe conclusions, Icpe methods, Icpe results, Ileus, Immunization, Impairment, Incidence, Incidence rate, Incidence rates, Inclusion criteria, Index date, Infanrixtm, Infarction, Infectious diseases, Informatics, Ingenix, Ingenix research database, Inhabitant, Inhaled, Inhaled corticosteroid, Inhaled corticosteroids, Inhaled steroids, Inhibitor, Initiator, Inpatient, Insurer, Internet, Intervention group, Ipci, Iptw, Ischemic, Isotretinoin, January, Jeanne, Jeffrey, Jennifer, Jerry avorn, Jimma, July, June, Jutland, Kaohsiung, Karolinska, Kevin, Kigs, Laba, Lamotrigine, Laparotomy, Large proportion, Lfts, Lipid, Lithium, Lithium serum levels, Lled, Logistic, Logistic regression, Lolkje, Longitudinal, Losartan, Lotrisone1, Lucie, Lynda, Magni, Malformation, Marianne, Maryland school, Mcgill, Meddra, Median, Medicaid, Medical costs, Medical history, Medical record, Medical records, Medicare, Medication, Medication adherence, Medication errors, Medline, Mellitus, Meloxicam, Menorrhagia, Meps, Metastatic, Methodology, Metrics, Mette, Mgps, Migraine, Mina, Minas gerais, Module, Mona, Monotherapy, Montreal, Morbidity, More drugs, More prescriptions, Multivariate, Muscat, Musculoskeletal, Myocardial infarction, Myopathy, Myositis, Nansaid, Nansaids, Naproxen, National institute, Nding, Ndings, Nefazodone, Netherlands, Neuroleptic, Neurology, Nijmegen, Nitrofurantoin, Nodm, Nonsteroidal, Nonusers, Norpd, Norway, Novartis, November, Nrxs, Nsaid, Nsaid users, Nursing homes, Observational studies, October, Odds ratio, Odds ratios, Odense, Olanzapine, Older adults, Oncology, Ongoing, Opiate, Opioids, Oradj, Orcs, Ortho, Osteoarthritis, Other antibiotics, Other antidepressants, Other countries, Other drugs, Other factors, Other statins, Outpatient, Overuse, Pancreatitis, Paquid, Paralytic, Parenteral, Paroxetine, Participant, Patient adherence, Pdrab, Pdud, Pediatric, Pediatric patients, Pennsylvania school, Peptic, Peptic ulcers, Perforated peptic ulcer, Perinatal, Period prevalence, Pharmaceutical, Pharmaceutical health services research, Pharmaceutical products, Pharmaceutical sciences, Pharmacist, Pharmacoeconomics, Pharmacoepidemiologic, Pharmacoepidemiological, Pharmacoepidemiology, Pharmacogenetics, Pharmacogenomics, Pharmacology, Pharmacotherapy, Pharmacovigilance, Pharmacy, Pharmacy claims, Pharmacy data, Pharmetrics, Pharmo, Physician sampling, Pimecrolimus, Pituitary apoplexy, Placebo, Pneumonia, Poisson, Polymorphism, Population controls, Postmarketing, Postoperative, Potassium monitoring, Potential confounders, Ppis, Predictor, Pregnancy, Pregnant women, Prescriber, Prescribers, Prescription, Prescription drugs, Preterm, Prevalence, Preventive medicine, Primary care, Primary care physicians, Primary prevention, Proactive, Progestin, Propensity, Propensity score, Propensity scores, Prophylaxis, Proportional hazard models, Propoxyphene, Prospective cohort study, Prostate cancer, Provider, Psoriasis, Psychotropic, Psychotropic drugs, Public health, Pulmonary disease, Purun, Pyloric, Qaboos, Quartile, Quintile, Quintiles, Ramq, Random sample, Randomized, Ranitidine, Rate ratios, Recent years, Receptor, Recurrence, Regie, Regimen, Regression, Regression analyses, Regression analysis, Regression model, Regression models, Relative risk, Remission, Renal, Repaglinide, Research triangle park, Respiratory failure, Retention time, Retrospective, Retrospective cohort study, Retrospective study, Retrospectively, Reuptake, Rfviia, Rheumatoid, Rheumatoid arthritis, Rheumatology, Risk, Risk factors, Risk management, Risk score, Rockville, Rofecoxib, Ropinirole, Rosuvastatin, Rosuvastatin initiators, Rotterdam, Saad, Saes, Same period, Sample size, Sars, Schizophrenia, Schneeweiss, Sdrs, Sebastian, Second year, Segalen, Selective serotonin reuptake inhibitors, September, Serious adrs, Serotonin, Sfuo, Shakir, Signal detection, Slone, Smoker, Smolensk, Software, Source population, Spontaneous reports, Squh, Ssri, Stabilizer, Statin, Statin therapy, Statin users, Statistical analysis, Stenosis, Steroid, Stillbirth, Stimulant, Stimulant treatment, Stockholm, Study period, Study population, Subgroup, Suicidal, Suicidal behavior, Suicidality, Suicide attempt, Sulfonamide, Sulfonamide drugs, Sulfonylurea, Sultan qaboos university hospital, Surrey, Svetlana, Systolic, Tacrolimus, Temazepam, Theophylline, Therapeutics, Therapy, Thiazide, Thromboembolic, Tianbaokang, Tiotropium, Tnsaid, Toine, Total cholesterol, Total costs, Total number, Toxicity, Travoprost, Trimester, Triptan, Triptans, Troms, Typical antipsychotics, Uips, Universite, Universite victor segalen, Uoroquinolone, Uoxetine, Uppsala, User, Usual care, Utilisation, Utilization, Utrecht, Utrecht institute, Utrecht university, Vaccination, Vaccine, Vaers, Valdecoxib, Validation, Vancouver, Venlafaxine, Venous, Vertebroplasty, Viagra, Vries, Waiver, Wang, Warfarin, Weight gain, Wenzhou, Whilst, Zolpidem, Zopiclone.
Url:
DOI: 10.1002/pds.1136
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002450
- to stream Istex, to step Curation: 002450
- to stream Istex, to step Checkpoint: 001B49
- to stream Main, to step Merge: 005016
- to stream Main, to step Curation: 004C88
- to stream Main, to step Exploration: 004C88
- to stream Psycho, to step Extraction: 000219
Links to Exploration step
ISTEX:B9E378DD4C580038D1F1732A86FE6FC1B45FC1EALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Abstracts of the 21st International Conference on Pharmacepidemiology & Therapeutic Risk Management</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B9E378DD4C580038D1F1732A86FE6FC1B45FC1EA</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/pds.1136</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-W5GK8ZMC-L/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002450</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002450</idno>
<idno type="wicri:Area/Istex/Curation">002450</idno>
<idno type="wicri:Area/Istex/Checkpoint">001B49</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001B49</idno>
<idno type="wicri:Area/Main/Merge">005016</idno>
<idno type="wicri:Area/Main/Curation">004C88</idno>
<idno type="wicri:Area/Main/Exploration">004C88</idno>
<idno type="wicri:Area/Psycho/Extraction">000219</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Abstracts of the 21st International Conference on Pharmacepidemiology & Therapeutic Risk Management</title>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Pharmacoepidemiology and Drug Safety</title>
<title level="j" type="sub">Abstracts of the 21st International Conference on Pharmacoepidemiology & Therapeutic Risk Management</title>
<title level="j" type="alt">PHARMACOEPIDEMIOLOGY AND DRUG SAFETY</title>
<idno type="ISSN">1053-8569</idno>
<idno type="eISSN">1099-1557</idno>
<imprint><biblScope unit="vol">14</biblScope>
<biblScope unit="issue">S2</biblScope>
<biblScope unit="page" from="S1">S1</biblScope>
<biblScope unit="page" to="S218">S218</biblScope>
<biblScope unit="page-count">218</biblScope>
<publisher>John Wiley & Sons, Ltd.</publisher>
<pubPlace>Chichester, UK</pubPlace>
<date type="published" when="2005-09">2005-09</date>
</imprint>
<idno type="ISSN">1053-8569</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1053-8569</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>1center</term>
<term>1department</term>
<term>1division</term>
<term>1epidemiology</term>
<term>1pharmacoepidemiology</term>
<term>1risk</term>
<term>1risk management strategy</term>
<term>2clinical</term>
<term>2department</term>
<term>2division</term>
<term>2epidemiology</term>
<term>2global</term>
<term>2research</term>
<term>2university</term>
<term>3department</term>
<term>3university</term>
<term>4department</term>
<term>5department</term>
<term>Aalborg</term>
<term>Aalborg hospital</term>
<term>Aarhus</term>
<term>Aarhus university hospital</term>
<term>Acei</term>
<term>Aceis</term>
<term>Acetaminophen</term>
<term>Acute pancreatitis</term>
<term>Adalimumab</term>
<term>Adenoma</term>
<term>Adhd</term>
<term>Adjuvant</term>
<term>Adjuvant chemotherapy</term>
<term>Administrative databases</term>
<term>Adrianne</term>
<term>Adrs</term>
<term>Adverse</term>
<term>Adverse drug reactions</term>
<term>Adverse effects</term>
<term>Adverse event</term>
<term>Adverse events</term>
<term>Aeds</term>
<term>Aers</term>
<term>Affective</term>
<term>Affective disorders</term>
<term>African americans</term>
<term>Aggressive incidents</term>
<term>Agonist</term>
<term>Akira</term>
<term>Alendronate</term>
<term>Algorithm</term>
<term>Allergy</term>
<term>Alosetron</term>
<term>Ambulatory</term>
<term>Ambulatory care</term>
<term>Amsp</term>
<term>Analgesic</term>
<term>Anaphylaxis</term>
<term>Angina</term>
<term>Angiotensin</term>
<term>Antenatal</term>
<term>Anthonius</term>
<term>Antibiotic</term>
<term>Anticholinergic</term>
<term>Anticoagulant</term>
<term>Anticonvulsant</term>
<term>Antidepressant</term>
<term>Antidiabetic</term>
<term>Antiepileptic</term>
<term>Antiepileptic drugs</term>
<term>Antihypertensive</term>
<term>Antihypertensive drugs</term>
<term>Antiplatelet</term>
<term>Antipsychotic</term>
<term>Anxiety disorders</term>
<term>Anxiolytic</term>
<term>Apds</term>
<term>Aplastic</term>
<term>Aplastic anemia</term>
<term>Apoplexy</term>
<term>April</term>
<term>Arb</term>
<term>Arrhythmia</term>
<term>Artifact</term>
<term>Aspirin</term>
<term>Asthma</term>
<term>Asthma drugs</term>
<term>Asthmatic</term>
<term>Atorvastatin</term>
<term>Atypical</term>
<term>Atypical antipsychotic</term>
<term>Atypical antipsychotics</term>
<term>Auburndale</term>
<term>August</term>
<term>Autocorrelation</term>
<term>Autoregressive</term>
<term>Autoregressive parameters</term>
<term>Avorn</term>
<term>Barcelona</term>
<term>Baseline</term>
<term>Baseline period</term>
<term>Bayes</term>
<term>Bayesian</term>
<term>Bcpnn</term>
<term>Belarus</term>
<term>Belo</term>
<term>Belo horizonte</term>
<term>Benzodiazepine</term>
<term>Binary</term>
<term>Binder</term>
<term>Biologic</term>
<term>Biostatistics</term>
<term>Bipolar</term>
<term>Birth defects</term>
<term>Bisphosphonates</term>
<term>Blocker</term>
<term>Blood pressure</term>
<term>Body mass index</term>
<term>Boston university</term>
<term>Bowel</term>
<term>Bowel surgery</term>
<term>Bpld</term>
<term>Brasilia</term>
<term>Breast cancer</term>
<term>Breastfeeding</term>
<term>Breastfeeding women</term>
<term>Brigham</term>
<term>British columbia</term>
<term>Bronchodilator</term>
<term>Caffeine</term>
<term>Calcium channel blockers</term>
<term>Calendar year</term>
<term>Cardiac</term>
<term>Cardiac arrest</term>
<term>Cardiac arrhythmias</term>
<term>Cardiac failure</term>
<term>Cardiology</term>
<term>Cardiotoxic</term>
<term>Cardiovascular</term>
<term>Cardiovascular disease</term>
<term>Cardiovascular events</term>
<term>Cardiovascular risk</term>
<term>Cardiovascular risk factors</term>
<term>Care population</term>
<term>Carlos</term>
<term>Carvedilol</term>
<term>Case reports</term>
<term>Causality</term>
<term>Causation</term>
<term>Ccbs</term>
<term>Celecoxib</term>
<term>Centre</term>
<term>Cert</term>
<term>Chang</term>
<term>Chapel hill</term>
<term>Chemotherapy</term>
<term>Chhd</term>
<term>Cimetidine</term>
<term>Cisapride</term>
<term>Claims data</term>
<term>Claims database</term>
<term>Clinical characteristics</term>
<term>Clinical epidemiology</term>
<term>Clinical outcomes</term>
<term>Clinical pharmacology</term>
<term>Clinical pharmacy</term>
<term>Clinical practice</term>
<term>Clinical trials</term>
<term>Clinician</term>
<term>Clomiphene</term>
<term>Clopidogrel</term>
<term>Clozapine</term>
<term>Codeine</term>
<term>Cognitive impairment</term>
<term>Cohort</term>
<term>Cohort entry</term>
<term>Cohort study</term>
<term>Coinsurance</term>
<term>Colloid</term>
<term>Colorectal</term>
<term>Colorectal cancer</term>
<term>Combination therapy</term>
<term>Community pharmacies</term>
<term>Comorbid</term>
<term>Comorbid depression</term>
<term>Comorbidities</term>
<term>Comorbidity</term>
<term>Comparators</term>
<term>Compliant</term>
<term>Computerized</term>
<term>Concomitant</term>
<term>Confounders</term>
<term>Congenital</term>
<term>Congenital malformations</term>
<term>Consumer reports</term>
<term>Contraceptive</term>
<term>Contraindication</term>
<term>Control group</term>
<term>Copd</term>
<term>Copd patients</term>
<term>Corinne</term>
<term>Coronary heart disease</term>
<term>Corticosteroid</term>
<term>Coumadin</term>
<term>Covariates</term>
<term>Coxibs</term>
<term>Current users</term>
<term>Daily dose</term>
<term>Daily doses</term>
<term>Daily practice</term>
<term>Data mining</term>
<term>Database</term>
<term>Dataset</term>
<term>Deborah</term>
<term>December</term>
<term>Denmark</term>
<term>Denominator</term>
<term>Depressed patients</term>
<term>Depressive</term>
<term>Dermatitis</term>
<term>Descriptive statistics</term>
<term>Determinant</term>
<term>Diabetes</term>
<term>Diabetes medications</term>
<term>Diabetes mellitus</term>
<term>Diagnosis</term>
<term>Diclofenac</term>
<term>Digoxin</term>
<term>Discontinuation</term>
<term>Discontinuation symptoms</term>
<term>Disease control</term>
<term>Disease severity</term>
<term>Disorder</term>
<term>Dispensings</term>
<term>Disproportionality</term>
<term>Diuretic</term>
<term>Dmards</term>
<term>Dmas</term>
<term>Dos</term>
<term>Dosing</term>
<term>Drug</term>
<term>Drug administration</term>
<term>Drug classes</term>
<term>Drug safety</term>
<term>Drug treatment</term>
<term>Drug utilization</term>
<term>Dtca</term>
<term>Dundee</term>
<term>Durham</term>
<term>Dysfunction</term>
<term>Dyslipidemia</term>
<term>Ebgm</term>
<term>Eibert</term>
<term>Elderly patients</term>
<term>Elderly people</term>
<term>Eligible patients</term>
<term>Email</term>
<term>Embase</term>
<term>Empiric</term>
<term>Endpoint</term>
<term>Epidemiologic</term>
<term>Epidemiology</term>
<term>Epidemiology biostatistics</term>
<term>Epilepsy</term>
<term>Epoetin</term>
<term>Erasmus</term>
<term>Erasmus university</term>
<term>Erythromycin</term>
<term>Esrd</term>
<term>Estrogen</term>
<term>Etanercept</term>
<term>Ethnicity</term>
<term>Etiology</term>
<term>Etoricoxib</term>
<term>Fadia</term>
<term>Fasting</term>
<term>February</term>
<term>Folic</term>
<term>Former users</term>
<term>Formulary</term>
<term>Fracture</term>
<term>Fracture risk</term>
<term>Frequentist</term>
<term>Further research</term>
<term>Further study</term>
<term>Galactorrhoea</term>
<term>Gastric</term>
<term>Gastric cancer</term>
<term>Gastrointestinal</term>
<term>Gastroprotective</term>
<term>Gender</term>
<term>General population</term>
<term>General practice</term>
<term>General practice research database</term>
<term>General practitioners</term>
<term>Generic</term>
<term>Generic substitution</term>
<term>Genotype</term>
<term>Gerais</term>
<term>Gerd</term>
<term>Gestation</term>
<term>Gestational</term>
<term>Glaxosmithkline</term>
<term>Glimepiride</term>
<term>Glucocorticoid</term>
<term>Glucose</term>
<term>Gnrh</term>
<term>Goal attainment</term>
<term>Gprd</term>
<term>Groningen</term>
<term>Guideline</term>
<term>Gures</term>
<term>H2ras</term>
<term>Harvard school</term>
<term>Hazard ratios</term>
<term>Hba1c</term>
<term>Hcru</term>
<term>Health care</term>
<term>Health care services</term>
<term>Health outcomes</term>
<term>Health services</term>
<term>Health solutions</term>
<term>Healthcare</term>
<term>Healthcare professionals</term>
<term>Heart disease</term>
<term>Heart failure</term>
<term>Helsinki</term>
<term>Hemorrhagic</term>
<term>Hemorrhagic stroke</term>
<term>Henrik</term>
<term>Heparin</term>
<term>Hepatic</term>
<term>Her2</term>
<term>Herbal</term>
<term>High doses</term>
<term>High levels</term>
<term>High risk</term>
<term>Higher risk</term>
<term>Hopital</term>
<term>Horizonte</term>
<term>Hormone replacement therapy</term>
<term>Hospital admission</term>
<term>Hospital admissions</term>
<term>Hospitalier</term>
<term>Hospitalisation</term>
<term>Hospitalization</term>
<term>Hrqol</term>
<term>Hyperkalemia</term>
<term>Hyperlipidemia</term>
<term>Hypersensitivity</term>
<term>Hypertension</term>
<term>Hypertensive</term>
<term>Hypertensive patients</term>
<term>Hypospadias</term>
<term>Ibuprofen</term>
<term>Icpe</term>
<term>Icpe background</term>
<term>Icpe conclusions</term>
<term>Icpe methods</term>
<term>Icpe results</term>
<term>Ileus</term>
<term>Immunization</term>
<term>Impairment</term>
<term>Incidence</term>
<term>Incidence rate</term>
<term>Incidence rates</term>
<term>Inclusion criteria</term>
<term>Index date</term>
<term>Infanrixtm</term>
<term>Infarction</term>
<term>Infectious diseases</term>
<term>Informatics</term>
<term>Ingenix</term>
<term>Ingenix research database</term>
<term>Inhabitant</term>
<term>Inhaled</term>
<term>Inhaled corticosteroid</term>
<term>Inhaled corticosteroids</term>
<term>Inhaled steroids</term>
<term>Inhibitor</term>
<term>Initiator</term>
<term>Inpatient</term>
<term>Insurer</term>
<term>Internet</term>
<term>Intervention group</term>
<term>Ipci</term>
<term>Iptw</term>
<term>Ischemic</term>
<term>Isotretinoin</term>
<term>January</term>
<term>Jeanne</term>
<term>Jeffrey</term>
<term>Jennifer</term>
<term>Jerry avorn</term>
<term>Jimma</term>
<term>July</term>
<term>June</term>
<term>Jutland</term>
<term>Kaohsiung</term>
<term>Karolinska</term>
<term>Kevin</term>
<term>Kigs</term>
<term>Laba</term>
<term>Lamotrigine</term>
<term>Laparotomy</term>
<term>Large proportion</term>
<term>Lfts</term>
<term>Lipid</term>
<term>Lithium</term>
<term>Lithium serum levels</term>
<term>Lled</term>
<term>Logistic</term>
<term>Logistic regression</term>
<term>Lolkje</term>
<term>Longitudinal</term>
<term>Losartan</term>
<term>Lotrisone1</term>
<term>Lucie</term>
<term>Lynda</term>
<term>Magni</term>
<term>Malformation</term>
<term>Marianne</term>
<term>Maryland school</term>
<term>Mcgill</term>
<term>Meddra</term>
<term>Median</term>
<term>Medicaid</term>
<term>Medical costs</term>
<term>Medical history</term>
<term>Medical record</term>
<term>Medical records</term>
<term>Medicare</term>
<term>Medication</term>
<term>Medication adherence</term>
<term>Medication errors</term>
<term>Medline</term>
<term>Mellitus</term>
<term>Meloxicam</term>
<term>Menorrhagia</term>
<term>Meps</term>
<term>Metastatic</term>
<term>Methodology</term>
<term>Metrics</term>
<term>Mette</term>
<term>Mgps</term>
<term>Migraine</term>
<term>Mina</term>
<term>Minas gerais</term>
<term>Module</term>
<term>Mona</term>
<term>Monotherapy</term>
<term>Montreal</term>
<term>Morbidity</term>
<term>More drugs</term>
<term>More prescriptions</term>
<term>Multivariate</term>
<term>Muscat</term>
<term>Musculoskeletal</term>
<term>Myocardial infarction</term>
<term>Myopathy</term>
<term>Myositis</term>
<term>Nansaid</term>
<term>Nansaids</term>
<term>Naproxen</term>
<term>National institute</term>
<term>Nding</term>
<term>Ndings</term>
<term>Nefazodone</term>
<term>Netherlands</term>
<term>Neuroleptic</term>
<term>Neurology</term>
<term>Nijmegen</term>
<term>Nitrofurantoin</term>
<term>Nodm</term>
<term>Nonsteroidal</term>
<term>Nonusers</term>
<term>Norpd</term>
<term>Norway</term>
<term>Novartis</term>
<term>November</term>
<term>Nrxs</term>
<term>Nsaid</term>
<term>Nsaid users</term>
<term>Nursing homes</term>
<term>Observational studies</term>
<term>October</term>
<term>Odds ratio</term>
<term>Odds ratios</term>
<term>Odense</term>
<term>Olanzapine</term>
<term>Older adults</term>
<term>Oncology</term>
<term>Ongoing</term>
<term>Opiate</term>
<term>Opioids</term>
<term>Oradj</term>
<term>Orcs</term>
<term>Ortho</term>
<term>Osteoarthritis</term>
<term>Other antibiotics</term>
<term>Other antidepressants</term>
<term>Other countries</term>
<term>Other drugs</term>
<term>Other factors</term>
<term>Other statins</term>
<term>Outpatient</term>
<term>Overuse</term>
<term>Pancreatitis</term>
<term>Paquid</term>
<term>Paralytic</term>
<term>Parenteral</term>
<term>Paroxetine</term>
<term>Participant</term>
<term>Patient adherence</term>
<term>Pdrab</term>
<term>Pdud</term>
<term>Pediatric</term>
<term>Pediatric patients</term>
<term>Pennsylvania school</term>
<term>Peptic</term>
<term>Peptic ulcers</term>
<term>Perforated peptic ulcer</term>
<term>Perinatal</term>
<term>Period prevalence</term>
<term>Pharmaceutical</term>
<term>Pharmaceutical health services research</term>
<term>Pharmaceutical products</term>
<term>Pharmaceutical sciences</term>
<term>Pharmacist</term>
<term>Pharmacoeconomics</term>
<term>Pharmacoepidemiologic</term>
<term>Pharmacoepidemiological</term>
<term>Pharmacoepidemiology</term>
<term>Pharmacogenetics</term>
<term>Pharmacogenomics</term>
<term>Pharmacology</term>
<term>Pharmacotherapy</term>
<term>Pharmacovigilance</term>
<term>Pharmacy</term>
<term>Pharmacy claims</term>
<term>Pharmacy data</term>
<term>Pharmetrics</term>
<term>Pharmo</term>
<term>Physician sampling</term>
<term>Pimecrolimus</term>
<term>Pituitary apoplexy</term>
<term>Placebo</term>
<term>Pneumonia</term>
<term>Poisson</term>
<term>Polymorphism</term>
<term>Population controls</term>
<term>Postmarketing</term>
<term>Postoperative</term>
<term>Potassium monitoring</term>
<term>Potential confounders</term>
<term>Ppis</term>
<term>Predictor</term>
<term>Pregnancy</term>
<term>Pregnant women</term>
<term>Prescriber</term>
<term>Prescribers</term>
<term>Prescription</term>
<term>Prescription drugs</term>
<term>Preterm</term>
<term>Prevalence</term>
<term>Preventive medicine</term>
<term>Primary care</term>
<term>Primary care physicians</term>
<term>Primary prevention</term>
<term>Proactive</term>
<term>Progestin</term>
<term>Propensity</term>
<term>Propensity score</term>
<term>Propensity scores</term>
<term>Prophylaxis</term>
<term>Proportional hazard models</term>
<term>Propoxyphene</term>
<term>Prospective cohort study</term>
<term>Prostate cancer</term>
<term>Provider</term>
<term>Psoriasis</term>
<term>Psychotropic</term>
<term>Psychotropic drugs</term>
<term>Public health</term>
<term>Pulmonary disease</term>
<term>Purun</term>
<term>Pyloric</term>
<term>Qaboos</term>
<term>Quartile</term>
<term>Quintile</term>
<term>Quintiles</term>
<term>Ramq</term>
<term>Random sample</term>
<term>Randomized</term>
<term>Ranitidine</term>
<term>Rate ratios</term>
<term>Recent years</term>
<term>Receptor</term>
<term>Recurrence</term>
<term>Regie</term>
<term>Regimen</term>
<term>Regression</term>
<term>Regression analyses</term>
<term>Regression analysis</term>
<term>Regression model</term>
<term>Regression models</term>
<term>Relative risk</term>
<term>Remission</term>
<term>Renal</term>
<term>Repaglinide</term>
<term>Research triangle park</term>
<term>Respiratory failure</term>
<term>Retention time</term>
<term>Retrospective</term>
<term>Retrospective cohort study</term>
<term>Retrospective study</term>
<term>Retrospectively</term>
<term>Reuptake</term>
<term>Rfviia</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatology</term>
<term>Risk</term>
<term>Risk factors</term>
<term>Risk management</term>
<term>Risk score</term>
<term>Rockville</term>
<term>Rofecoxib</term>
<term>Ropinirole</term>
<term>Rosuvastatin</term>
<term>Rosuvastatin initiators</term>
<term>Rotterdam</term>
<term>Saad</term>
<term>Saes</term>
<term>Same period</term>
<term>Sample size</term>
<term>Sars</term>
<term>Schizophrenia</term>
<term>Schneeweiss</term>
<term>Sdrs</term>
<term>Sebastian</term>
<term>Second year</term>
<term>Segalen</term>
<term>Selective serotonin reuptake inhibitors</term>
<term>September</term>
<term>Serious adrs</term>
<term>Serotonin</term>
<term>Sfuo</term>
<term>Shakir</term>
<term>Signal detection</term>
<term>Slone</term>
<term>Smoker</term>
<term>Smolensk</term>
<term>Software</term>
<term>Source population</term>
<term>Spontaneous reports</term>
<term>Squh</term>
<term>Ssri</term>
<term>Stabilizer</term>
<term>Statin</term>
<term>Statin therapy</term>
<term>Statin users</term>
<term>Statistical analysis</term>
<term>Stenosis</term>
<term>Steroid</term>
<term>Stillbirth</term>
<term>Stimulant</term>
<term>Stimulant treatment</term>
<term>Stockholm</term>
<term>Study period</term>
<term>Study population</term>
<term>Subgroup</term>
<term>Suicidal</term>
<term>Suicidal behavior</term>
<term>Suicidality</term>
<term>Suicide attempt</term>
<term>Sulfonamide</term>
<term>Sulfonamide drugs</term>
<term>Sulfonylurea</term>
<term>Sultan qaboos university hospital</term>
<term>Surrey</term>
<term>Svetlana</term>
<term>Systolic</term>
<term>Tacrolimus</term>
<term>Temazepam</term>
<term>Theophylline</term>
<term>Therapeutics</term>
<term>Therapy</term>
<term>Thiazide</term>
<term>Thromboembolic</term>
<term>Tianbaokang</term>
<term>Tiotropium</term>
<term>Tnsaid</term>
<term>Toine</term>
<term>Total cholesterol</term>
<term>Total costs</term>
<term>Total number</term>
<term>Toxicity</term>
<term>Travoprost</term>
<term>Trimester</term>
<term>Triptan</term>
<term>Triptans</term>
<term>Troms</term>
<term>Typical antipsychotics</term>
<term>Uips</term>
<term>Universite</term>
<term>Universite victor segalen</term>
<term>Uoroquinolone</term>
<term>Uoxetine</term>
<term>Uppsala</term>
<term>User</term>
<term>Usual care</term>
<term>Utilisation</term>
<term>Utilization</term>
<term>Utrecht</term>
<term>Utrecht institute</term>
<term>Utrecht university</term>
<term>Vaccination</term>
<term>Vaccine</term>
<term>Vaers</term>
<term>Valdecoxib</term>
<term>Validation</term>
<term>Vancouver</term>
<term>Venlafaxine</term>
<term>Venous</term>
<term>Vertebroplasty</term>
<term>Viagra</term>
<term>Vries</term>
<term>Waiver</term>
<term>Wang</term>
<term>Warfarin</term>
<term>Weight gain</term>
<term>Wenzhou</term>
<term>Whilst</term>
<term>Zolpidem</term>
<term>Zopiclone</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Psycho/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000219 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Psycho/Analysis/biblio.hfd -nk 000219 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Psycho |étape= Analysis |type= RBID |clé= ISTEX:B9E378DD4C580038D1F1732A86FE6FC1B45FC1EA |texte= Abstracts of the 21st International Conference on Pharmacepidemiology & Therapeutic Risk Management }}
This area was generated with Dilib version V0.6.33. |